Ilinca Serbanescu

Ilinca Serbanescu

Auto-generated profile, based on publicly available information

Ilinca Serbanescu

Institute of Psychology, Heidelberg University, Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
VMVeronika I. Müller
Veronika I. Müller
ECEdna C. Cieslik
Edna C. Cieslik
ISIlinca Serbanescu
Ilinca Serbanescu
ALAngela R. Laird
Angela R. Laird
PFPeter T. Fox
Peter T. Fox
SESimon B. Eickhoff
Simon B. Eickhoff
Unipolar depression (UD) is one of the leading causes of disease burden worldwide.1 In line with the characteristic symptoms of low mood and reduced activity and concentration,2 patients with UD show impairments of emotional and cognitive processing.3,4 Numerous neuroimaging experiments5-8 have investigated the neural correlates underlying these impairments, but their results vary considerably. This variance might be attributable to sampling effects in this heterogeneous disorder but also to the high degree of experimental and analytic flexibility in neuroimaging. Consequently, several quantitative meta-analyses have been performed to delineate brain regions consistently implicated in UD9-14 (Figure 1 illustrates the different steps of a meta-analysis). However, these meta-analyses also yielded inconsistent findings (Figure 2).

1 July 2021 in Journal of Affective Disorders
Verified
Journal Article
Open access
BHBridget Hogg
Bridget Hogg
JMJoan Carles Medina
Joan Carles Medina
IGItxaso Gardoki-Souto
Itxaso Gardoki-Souto
ISIlinca Serbanescu
Ilinca Serbanescu
AMAna Moreno-Alcázar
Ana Moreno-Alcázar
BABenedikt Amann
Benedikt Amann
Depression and anxiety are the most prevalent mental health difficulties in the workplace, costing the global economy $1 trillion each year. Evidence indicates that symptoms may be reduced by interventions in the workplace. This paper is the first to systematically review psychosocial interventions for depression, anxiety, and suicidal ideation and behaviours in small-to medium-size enterprises (SMEs). A systematic search following PRISMA guidelines, registered in PROSPERO (CRD42020156275), was conducted for psychosocial interventions targeting depression, anxiety, and suicidal ideation/behaviour in SMEs. The PubMed, PsycINFO, Scopus, and two specific occupational health databases were searched, as well as four databases for grey literature, without time limit until 2nd December 2019. In total, 1283 records were identified, 70 were retained for full-text screening, and seven met the inclusion criteria: three randomised controlled trials (RCTs), three before and after designs and one non-randomised trial, comprising 5111 participants. Study quality was low to moderate according to the Quality Assessment Tool for Quantitative Studies. Five studies showed a reduction in depression and anxiety symptoms using techniques based on cognitive behavioural therapy (CBT), two reported no significant change. Low number and high heterogeneity of interventions and outcomes, high attrition and lack of rigorous RCTs. Preliminary evidence indicates CBT-based interventions can be effective in targeting symptoms of depression and anxiety in SME employees. There may be unique challenges to implementing programmes in SMEs. Further research is needed in this important area.

6 January 2018 in Psychotherapy and Psychosomatics
Verified
Journal Article
Closed access
PDF file
JKJan Philipp Klein
Jan Philipp Klein
NENele Erkens
Nele Erkens
USUlrich Schweiger
Ulrich Schweiger
LKLevente Kriston
Levente Kriston
PBPaul Bausch
Paul Bausch
ESElisabeth Schramm
Elisabeth Schramm

21 December 2020 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
ISIlinca Serbanescu
Ilinca Serbanescu
MBMatthias Backenstrass
Matthias Backenstrass
SDSarah Drost
Sarah Drost
BWBernd Weber
Bernd Weber
HWHenrik Walter
Henrik Walter
DSDieter Schoepf
Dieter Schoepf
Importance: In the treatment of persistent depressive disorder (PDD), disorder-specific Cognitive Behavioral Analysis System of Psychotherapy (CBASP) has been shown to be superior to Supportive Psychotherapy (SP) in outpatients. It remains to clear which subgroups of patients benefit equally and differentially from both psychotherapies.Objective: To identify those patient-level baseline characteristics that predict a comparable treatment effectiveness of CBASP and SP and those that moderate the differential effectiveness of CBASP compared to SP.Design, setting and participants: In this analysis of a 48-week multicenter randomized clinical trial comparing CBASP to SP in adult antidepressant-free outpatients with early-onset PDD, we evaluated baseline variables from the following domains as potential predictors and moderators of treatment effectiveness: socio-demography, clinical status, psychosocial and global functioning, life quality, interpersonal problems, childhood trauma, treatment history, preference for psychotherapy, and treatment expectancy.Interventions: A 48-week treatment program with 32 sessions of either CBASP or SP.Main outcomes and measures: Depression severity measured by the 24-item Hamilton Rating Scale for Depression (HRSD-24) at week 48.Results: From N = 268 randomized outpatients, N = 209 completed the 48-week treatment program. CBASP completers had significantly lower post-treatment HRSD-24 scores than SP completers (meanCBASP=13.96, sdCBASP= 9.56; meanSP= 16.69, sdSP= 9.87; p = 0.04). A poor response to both therapies was predicted by higher baseline levels of clinician-rated depression, elevated suicidality, comorbid anxiety, lower social functioning, higher social inhibition, moderate-to-severe early emotional or sexual abuse, no preference for psychotherapy, and the history of at least one previous inpatient treatment. Moderator analyses revealed that patients with higher baseline levels of self-rated depression, comorbidity of at least one Axis-I disorder, self-reported moderate-to-severe early emotional or physical neglect, or at least one previous antidepressant treatment, had a significantly lower post-treatment depression severity with CBASP compared to SP (all p < 0.05).Conclusions and relevance: A complex multifactorial interaction between severe symptoms of depression, suicidality, and traumatic childhood experiences characterized by abuse, social inhibition, and anxiety may represent the basis of non-response to psychotherapy in patients with early onset PDD. Specific psychotherapy with CBASP might, however, be more effective and recommendable for a variety of particularly burdened patients compared to SP.

1 January 2020 in Behaviour Research and Therapy
Verified
Journal Article
Closed access
ISIlinca Serbanescu
Ilinca Serbanescu
HWHenrik Walter
Henrik Walter
KSKnut Schnell
Knut Schnell
HKHenrik Kessler
Henrik Kessler
BWBernd Weber
Bernd Weber
DSDieter Schoepf
Dieter Schoepf

1 June 2016 in Public Health Forum
Verified
Journal Article
Closed access
ISIlinca Serbanescu
Ilinca Serbanescu
HBHarald Baumeister
Harald Baumeister
Zusammenfassung: Klinische und epidemiologische Studien belegen, dass psychische Störungen häufige Begleiterscheinungen chronischer körperlicher Erkrankungen darstellen. Obwohl die rechtzeitige und korrekte Erkennung der somatopsychischen Komorbidität bedeutsame Implikationen für die Therapie und den Verlauf der assoziierten Erkrankungen hat, findet sie nur in einem begrenzten Teil der Fälle statt. Dabei kann eine frühzeitige Diagnostik und Behandlung der komorbiden psychischen Störung das Ausmaß ihrer Symptomatik verringern und die Lebensqualität der doppeltbelasteten Patienten entscheidend verbessern.